Efficacy and safety of erdafitinib in pediatric patients with advanced solid tumors and FGFR alterations in the phase 2 RAGNAR trial Meeting Abstract
| Authors: | Witt, O.; Sait, S. F.; Diez, B. D.; Cardoso, A.; Reardon, D. A.; Welsh, L.; Shih, K. C.; Baldini, C.; Massard, C.; Loriot, Y.; Pant, S.; Sweiti, H.; Thomas, S.; Hammond, C.; Najmi, S.; Triantos, S.; Crow, L.; Geoerger, B. |
| Abstract Title: | Efficacy and safety of erdafitinib in pediatric patients with advanced solid tumors and FGFR alterations in the phase 2 RAGNAR trial |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402285 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.10002 |
| Notes: | Meeting Abstract: 10002 -- Source: Wos |
